Strategic partnerships Renalis has actively pursued partnerships to expand patient care delivery for pelvic health disorders, including collaborations with Nurse Navigator Solutions and a planned advanced navigation platform. This indicates a sales opportunity to offer scalable digital therapeutics integrations and care coordination tools to partner networks and navigators.

Clinical adoption The CeCe digital therapeutic targets first-line treatment for overactive bladder and is delivered via mobile apps on iOS and Android. This suggests opportunities to bundle or integrate with electronic health records, patient engagement platforms, and remote monitoring solutions used by healthcare systems seeking noninvasive OAB management.

Healthcare expansion Renalis relocated HQ to Cleveland and has a collaboration with University Hospitals for a proof-of-concept study, signaling a growth trajectory in the Northeast with potential for pilot programs, clinical partnerships, and regional deployments within similar health systems.

Funding signals Pre-seed funding and ongoing advisory involvement (Strategic Advisory Board) indicate late-stage product validation and readiness for customer pilots. This presents an avenue to approach early adopters in pelvic health and digital therapeutics with proven interest and momentum.

Product ecosystem Past acquisition of Vesica and a maturing tech stack (AWS, mobile front-end, web store, structured data capabilities) point to integration-ready capabilities. This creates sales opportunities around data interoperability, analytics, and seamless integration with partner apps, clinics, and device ecosystems.